USAID's NTD Program

USAID is a global leader in large-scale implementation of integrated treatment programs for NTDs, focusing on the scale-up of mass drug administration to target the control and/or elimination of lymphatic filariasis, blinding trachoma, onchocerciasis, schistosomiasis, and intestinal worms. The program currently supports 25 countries and regional programs in Africa and the Americas to reach treatment targets and to monitor and evaluate the programs to document achievement of control and elimination goals. Over the past 7 years, the U.S. Government has leveraged $6.7 billion in donated medicines, resulting in the delivery of more than 1 billion treatments to approximately 467.9 million people through our integrated programs. USAID's NTD goals contribute to: - Elimination of onchocerciasis in the Americas by 2016; - Elimination of lymphatic filariasis globally by 2020; - Elimination of blinding trachoma globally by 2020.